These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 6259209
1. Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3',5'-monophosphate in gallbladder epithelial cells of man. Comparison with the guinea pig. Dupont C, Broyart JP, Broer Y, Chenut B, Laburthe M, Rosselin G. J Clin Invest; 1981 Mar; 67(3):742-52. PubMed ID: 6259209 [Abstract] [Full Text] [Related]
2. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. Jiang S, Kopras E, McMichael M, Bell RH, Ulrich CD. Cancer Res; 1997 Apr 15; 57(8):1475-80. PubMed ID: 9108448 [Abstract] [Full Text] [Related]
3. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB, Niewiadomski P, Nowak JZ. Gen Comp Endocrinol; 2004 Jun 15; 137(2):187-95. PubMed ID: 15158130 [Abstract] [Full Text] [Related]
4. Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture. Laburthe M, Rousset M, Chevalier G, Boissard C, Dupont C, Zweibaum A, Rosselin G. Cancer Res; 1980 Jul 15; 40(7):2529-33. PubMed ID: 6248206 [Abstract] [Full Text] [Related]
5. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture. Boissard C, Marie JC, Hejblum G, Gespach C, Rosselin G. Cancer Res; 1986 Sep 15; 46(9):4406-13. PubMed ID: 3015387 [Abstract] [Full Text] [Related]
6. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells. Broyart JP, Dupont C, Laburthe M, Rosselin G. J Clin Endocrinol Metab; 1981 Apr 15; 52(4):715-21. PubMed ID: 6259191 [Abstract] [Full Text] [Related]
7. Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 2. Characterization and structural requirements of the stimulatory effect of vasoactive intestinal peptide on production of adenosine 3':5'-monophosphate. Laburthe M, Prieto JC, Amiranoff B, Dupont C, Hui Bon Hoa D, Rosselin G. Eur J Biochem; 1979 May 15; 96(2):239-48. PubMed ID: 88368 [Abstract] [Full Text] [Related]
8. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex. Zawilska JB, Niewiadomski P, Nowak JZ. Pol J Pharmacol; 2004 May 15; 56(2):203-11. PubMed ID: 15156071 [Abstract] [Full Text] [Related]
9. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors. Virgolini I, Yang Q, Li S, Angelberger P, Neuhold N, Niederle B, Scheithauer W, Valent P. Cancer Res; 1994 Feb 01; 54(3):690-700. PubMed ID: 7905785 [Abstract] [Full Text] [Related]
10. Cyclic AMP in pancreatic acinar cells: effects of gastrointestinal hormones. Gardner JD, Conlon TP, Adams TD. Gastroenterology; 1976 Jan 01; 70(1):29-35. PubMed ID: 173615 [Abstract] [Full Text] [Related]
11. Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by intracellular accumulation of cyclic adenosine 3'-5'-monophosphate. Inoue Y, Kaku K, Kaneko T, Yanaihara N, Kanno T. Endocrinology; 1985 Feb 01; 116(2):686-92. PubMed ID: 2578385 [Abstract] [Full Text] [Related]
12. Receptors for vasoactive intestinal peptide and secretin on guinea pig pancreatic acini. Zhou ZC, Gardner JD, Jensen RT. Peptides; 1987 Feb 01; 8(4):633-7. PubMed ID: 2819833 [Abstract] [Full Text] [Related]
13. Interaction of peptides related to secretin with hormone receptors on pancreatic acinar cells. Gardner JD, Conlon TP, Fink ML, Bodanszky M. Gastroenterology; 1976 Dec 01; 71(6):965-70. PubMed ID: 186350 [Abstract] [Full Text] [Related]
14. Quantitative studies of vasoactive intestinal peptide (VIP) binding sites and VIP-induced adenosine 3':5'-monophosphate production in epithelial cells from duodenum, jejunum, ileum, cecum, colon and rectum in the rat. Prieto JC, Laburthe M, Hoa DH, Rosselin G. Acta Endocrinol (Copenh); 1981 Jan 01; 96(1):100-6. PubMed ID: 6257013 [Abstract] [Full Text] [Related]
15. Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung. Carstairs JR, Barnes PJ. J Pharmacol Exp Ther; 1986 Oct 01; 239(1):249-55. PubMed ID: 3020233 [Abstract] [Full Text] [Related]
16. Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor. Xia M, Sreedharan SP, Bolin DR, Gaufo GO, Goetzl EJ. J Pharmacol Exp Ther; 1997 May 01; 281(2):629-33. PubMed ID: 9152366 [Abstract] [Full Text] [Related]
17. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R. Mol Cell Neurosci; 2006 Feb 01; 31(2):193-209. PubMed ID: 16226889 [Abstract] [Full Text] [Related]